Medical Devices

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

Wellspect HealthCare's new Surity™ catheter targets a growing market, offering a non-invasive solution designed for comfort, discretion, and dignity.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

A new purpose-built CPAP battery uses safer, longer-lasting tech to deliver uninterrupted sleep, whether at home, camping, or during a power outage.

With double-digit growth and key US acquisitions, ESTEVE is rapidly expanding. But it's the firm's B Corp status that may redefine success in pharma.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

Benchmark Electronics raises its 2026 forecast after strong Q1 results, driven by sector growth and a successful two-year strategic transformation.

The closure of a renowned NYC eye care provider creates an unprecedented opportunity to acquire its high-tech surgical equipment at a major online auction.

New Phase III data shows a dual-action drug delivers significant weight loss while targeting liver health, positioning it as a major new player in the market.

A novel immunotherapy that freezes and infuses tumors shows an 87% response rate in advanced prostate cancer, aiming to turn local treatment into a systemic attack.

Swedish firm Navinci launches its Omni kit, targeting the spatial interactomics market with a new tool to visualize protein networks directly in tissue.

Marking its 10th year, The Odlum Brown Forum Pitch awarded three innovative women-led startups and raised a record $1.52 million to tackle the funding gap.

A new five-year partnership seeks to bridge the gap between clinical insight and investment, speeding up patient access to new medical technologies.

The grocer's 2025 Impact Report reveals major strides in fighting hunger, promoting public health, and fostering an inclusive culture from the inside out.

A new study shows RIVANNA's Accuro XV allows staff with minimal training to get diagnostic images, promising to speed up care and reduce ER wait times.

A new device gets the CE Mark to modernize a 60-year-old cardiac test, promising clearer, faster diagnosis of shunts linked to stroke in millions.

Imviva Biotech's new CAR-T therapy shows potential for durable remission in lupus, moving advanced cell treatments beyond cancer to autoimmune disease.

A new microwave-based technology arrives in North America, promising comfortable cellulite reduction and a disruptive consumable-free model for clinics.